AIC
AGN

Ameritas Investment Company’s Allergan plc AGN Stock Holding History

Ameritas Investment Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-343
Closed -$61K – 1819
2020
Q1 		$61K Buy
343
+111
+48% +$20.9K 0.01% 637
2019
Q4 		$44K Sell
232
-120
-34% -$21.6K 0.01% 597
2019
Q3 		$60K Buy
+352
New +$57.3K 0.01% 617
2019
Q2 		– Sell
-90
Closed -$13K – 965
2019
Q1 		$13K Sell
90
-1,928
-96% -$280K ﹤0.01% 620
2018
Q4 		$270K Buy
+2,018
New +$331K 0.06% 245

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Ameritas Investment Company's AGN Position: Q2 2020 in Review

Ameritas Investment Company sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 343 shares — an estimated $61K sold.

Ameritas Investment Company first reported a position in AGN in Q4 2018 and held it in 5 quarters. The position peaked at $270K in Q4 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Ameritas Investment Company reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Ameritas Investment Company sold 343 Allergan plc shares in Q2 2020, an estimated $61K.
  • Ameritas Investment Company first reported a position in Allergan plc in Q4 2018 and held it in 5 quarters.
  • Ameritas Investment Company's Allergan plc position peaked at $270K in Q4 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Ameritas Investment Company's 13F filing for Q2 2020, filed 14 Aug 2020.